What is anyone's department's practice hen transporting light sensitive medications from the pharmacy to the ADCs on the floors? Since the medication will be exposed to light for an unknown period of time, are they transported in light sensitive bags? Is anyone aware of a best practice on this topic?

Hi all -

My organization is looking to implement STOP BANG for all of our patients (it's a nursing assessment tool to determine if a patient is at high risk for an opioid adverse event). We do it in the peri-op setting currently, but are looking to expand house-wide.

That being said, we want to determine best practices from other organizations - what monitoring is in place (pulse ox vs. capnography), what "score" necessitates what intervention/monitoring, etc.

Is anyone using STOP BANG house-wide?

Thanks,
Elizabeth

Dear all,

For those of you who have a PGY1 / PGY 2 residency with focus on medication safety, can you please share your learning description for the medication safety rotation.

Much appreciated,
Rabih

What are you using to replace aminophylline for dipyridamole induced SEs following nuc med stress testing? Any experience with or plan to use slow IV puss caffeine citrate?

Hi all -

Does anyone have any non-technology related strategies to address mislabeling errors for IV infusions? For example, label is for amiodarone but I attach adenosine to it instead. Label will still scan as correct since you're not scanning the product barcode.

Thanks!
Elizabeth

Hi all, I've noticed a few hospitals that are drawing up T-VEC in their hoods into syringes to dispense and was wondering if anyone else is doing this?

The PI does not recommend this and states not to do this until right before administration - previously in my last hospital we also dispensed the vials directly to the consultant.

I was wondering as well is there anyone here that was involved in the clinical trials for T-VEC and hence might be privvy to longer stability data/reconstitution times used during the trial that might differ from what is being marketed.

Does anyone have a framework for what to evaluate when comparing biomedical service vendors? From the pharmacy perspective, availability and expertise in updating non-wireless libraries is what comes to mind.
Appreciate any thoughts from others who have been involved in a similar process.
thanks

We've considered adding this "class" to our high alert medication list. Only happens very rarely, since we already have may approved "double concentrated" drips. I supposed it would be challenging to even detect how often non-standard concentrations are built.

I'm pretty concerned that a surveyor may not appreciate seeing this class on our list. Although acknowledging the risk and trying to address it may be better than ignoring it?

Do people treat mesna and leucovorin as a chemo medication requiring a double signature by nursing because of the complicated dosing calculations and conversions (IV to PO) involved with it? Thank you.

hello!

I was writing today to see if any of you that practice in the ambulatory space might be able to provide insight into your practices in regards to this question:

Do you currently "dispense" medications out of / from your physician (outpatient) offices?

(if so, what medications are you dispensing?, are there certain criteria that have to be met?, who has oversight?, what sort of process is involved including meeting regulatory requirements / labeling, etc.)

Thanks in advance!
Emily